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Abstract
Mycoplasma genitalium is an appealing model of a minimal cell and synthetic biology study, and it
was one of the ﬁrst organisms whose genomewas fully sequenced and chemically synthesized. De-
spite its usefulness as a model organism, many genetic tools well established for other microorgan-
isms are not currently available in mycoplasmas. We have developed several vectors to adapt the
Cre-lox technology for genome engineering in M. genitalium, providing an all-in-one construct
that could be also useful to obtain unmarked genetic modiﬁcations in many other slow growing mi-
croorganisms. This construct contains a modiﬁed promoter sequence based in TetR system that ex-
hibits an enhanced control on Cre recombinase expression, virtually abolishing the presence of this
recombinase in the absence of inducer. This allows to introduce the Cre recombinase gene and the
desired geneticmodiﬁcation in a single transformation step. In addition, this inducible promotermay
be a very promising tool for a wide range of molecular applications.
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1. Introduction
Site-speciﬁc recombination systems such as those based in Cre/lox
from bacteriophage P1,1,2 Xis/att from bacteriophage λ3 or FLP/
FRT from Sacharomyces cerivisiae4 have been widely used for genome
engineering in microorganisms, complex eukaryotic cells and mam-
mals.5–8 In a ﬁrst step, the modiﬁcation including the recombinogenic
sequences is introduced in the genome. In second transformation or
transfection step, a recombinase coded in a suicide plasmid, a curable
plasmid or any other delivery vector catalyzes a recombination be-
tween two site-speciﬁc recognition sites, thus generating the desired
DNA integration, excision or inversion. It is also possible to have
the recombinase as a transgene in the genome of the organism of
study and introduce the recombinase by genetic crossing. However,
this approach has to deal with the recombinase off-site effects and
toxicity which have been broadly described.9–11 Among the different
site-speciﬁc recombination systems, the Cre-lox shows a remarkable
plasticity. Cre recombinase recognizes multiple loxP sites1,2 allowing
the design of variant sites such as lox66, lox2272, lox71, loxN, loxLE
or loxRE.12–16 All these variant lox sites have been tested for compat-
ibility and recombination efﬁciency.
Mycoplasma genitalium is an emerging sexually transmitted
human pathogen and is one of the free-living organisms with the smal-
lest genome.17 Besides being the causative agent of non-chlamydial
and non-gonococcal urethritis,18 this microorganism with a 580 kb
genome is an appealing model of a minimal cell and synthetic biology
studies, and it was one of the ﬁrst organisms whose genome was fully
sequenced19 and chemically synthesized.20 Multiple studies aiming to
understand the cell function were developed with this microorganism,
from the determination of non-essential genes in axenic culture21 to
modelling the phenotype prediction from a genotype.22 This organism
is also a model for system biology studies such as the ones performed
to its close relative Mycoplasma pneumoniae.23–28
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Many genetic tools well established for other microorganisms are
not available in mycoplasmas.29 Furthermore, most of the tools avail-
able, such as transposons, mini-transposons, replicative plasmids and
suicide vectors for gene replacement rely on the incorporation of selec-
tive markers. These markers may interfere with the cell metabolism,
and their use is a limiting factor for genome engineering given the
low number of selection markers available. To circumvent these pro-
blems, we were aimed to implement the Cre-lox technology inM. gen-
italium by two different approaches. First, we used a suicide vector
bearing Cre recombinase gene under the control of a constitutive
promoter following similar procedures to those used in other organ-
isms.30 Finally, we implemented a time-saving method based on
TetR repressor by engineering the inducible Pxyl/TetO2 promoter pre-
viously used in Mycoplasma agalactie.31 This modiﬁed promoter
tightly controls the expression of the Cre recombinase gene, which
allows the introduction of both the desired mutation and Cre recom-
binase in a single step.
2. Materials and methods
2.1. Bacterial strains and culture conditions
Escherichia coli XL-1Blue was grown at 37°C in LB medium or
LB agar plates containing 100 µg/ml of ampicillin.32 M. genitalium
G37 wild-type strain (NCTC 10195) and its isogenic mutant deriva-
tives (Supplementary Table S1) were grown at 37°C under 5% CO2
in 75 cm2 tissue culture ﬂasks containing 20 ml of SP4 medium.33
M. genitaliumwas transformed as previously described.34 For mutant
colony isolation, transformant cells were grown for 3 weeks in SP4
plates supplemented with 34 µg ml−1 chloramphenicol or 2 µg ml−1
tetracycline.
2.2. DNA manipulations
DNAmanipulations were performed according to procedures in Sam-
brook & Russell.35 Genomic DNA from M. genitalium was isolated
using the E.Z.N.A. Bacterial DNA Kit (Omega BIO-TEK). Plasmid
DNAs were obtained using the Fast Plasmid Mini Eppendorf Kit
(VWR). Preparative amounts of plasmid DNAs were puriﬁed using
the GenElute™ HP Plasmid Midiprep Kit (Sigma).
PCR ampliﬁcationwas performed using PhusionHigh-Fidelity DNA
Polymerase (Thermo Scientiﬁc) and adjusting the annealing temperature
according to the primers used (Supplementary Table S2). Puriﬁcation of
PCR products and DNA digested fragments from agarose gels was per-
formed by using NucleoSpin Gel and PCR Clean-up (Macherey-Nagel)
kits. FastDigest restriction enzymes (Thermo Scientiﬁc) and T4 DNA li-
gase (Roche) were used according to manufacturer instructions.
2.3. Plasmids construction
Primers used in this work are in Supplementary Table S2. All the con-
structs below were screened by restriction analysis and conﬁrmed by
Sanger sequencing.
pΔMG_217Cre (Supplementary Fig. S1A) was constructed as fol-
lows. First, TetR repressor under spiralin promoter control was ampli-
ﬁed by PCR from pMT85-XTST31 using the primers 5 KpnI Pspi-TetR
and 3 SpeI lox 66 PstI TetR, which incorporates the lox66 sequence
between SpeI and PstI restriction sites. This PCR fragment was then
digestedwith SpeI andKpnI to generate cohesive ends. Xylose promoter
including TetO regions (Pxyl/TetO2) was ampliﬁed using the primers
5_KpnI_Pxyl/TetO2 and 3_NcoI_Pxyl/TetO2 from pMT85-XTST.
This PCR product was KpnI–NcoI digested and ligated into a Litmus28
vector restricted with the same enzymes. Then, an ExSite mutagenesis
PCR36 was performed using the primers 5_NdeI_TetO2 and 3_NdeI_
Litmus28 to modify the inducible promoter by deleting the region
from nt 7,200 to nt 7,276 of pMT85-XTST, which includes the RBS
sequence, obtaining in this way the Pxyl/TetO2mod promoter cassette
(Supplementary Fig. S3). Cre recombinase was ampliﬁed by PCR from
pSH6214 using the primers 5_NdeI_Cre and 3_MluI_Cre and digested
with NdeI and MluI. Chloramphenicol resistance gene (cat) was am-
pliﬁed from pMTnCat37 using the primers 5_MluI_pmg438_CmR
and 3_ApaI_lox66_SalI_CmR, which incorporate the sequence of
lox66 between the ApaI and SalI restriction sites. This PCR fragment
was then digested with MluI and ApaI. Pxyl/TetO2mod was excised
from Litmus28 using the NdeI andMluI sites, mixed with the digested
PCR products and ligated into a pBSK previously digested with SpeI
and ApaI restriction enzymes. The resulting plasmid was named
pBSK-TetR-Pxyl/TetO-Cre-cat. In a second step, a 919-bp PCR frag-
ment containing the upstream homology region (UHR) and 60 bp of
the 5′ end of MG_217 was ampliﬁed by using the primers 5_XhoI_
SacI_BE_mg217 and 3_SpeI_AscI_BE_mg217. The resulting PCR
fragment was digested with XhoI and SpeI. Another 976 bp PCR frag-
ment containing the last 139 bp of MG_217 and the corresponding
downstream homology region (DHR) was ampliﬁed using the primers
5_ApaI_BD_mg217 and 3_BamHI_NotI_BD_mg217 and further di-
gested with ApaI and BamHI. Finally, both PCR fragments were
mixed with the 2.9 kb SpeI-ApaI fragment from pBSK-TetR-Pxyl/
TetO-Cre-cat and ligated to a pBSK previously digested with XhoI
and BamHI.
pMTnTc66Cat66 (Supplementary Fig. S1B) was constructed as
follows. Cat gene was ampliﬁed by PCR from pMTnCat using the
5_SpeI_lox66_PstI_pmg438_CmR and 3_ApaI_lox66_SalI_CmR
primers, which incorporates the sequence of lox66 between ApaI
and SalI the restriction sites. This PCR product was digested with
SpeI and ApaI restriction enzymes, mixed with EcoRI-SpeI digested
tetracycline resistance gene excised from pMTnTetM43834 and ligated
to the vector pMTn400134 previously digested with EcoRI and ApaI.
pGmR (Supplementary Fig. S1C) was constructed as follows. The
aac(6′)-aph(2″) gene that confers gentamycin resistance was ampliﬁed
by PCR from pMTnGm34 using the primers 5_BamHI_pM438-
GmRshort and 3_BamHI_GmR_short. The ampliﬁcation with these
primers only include the ORF region (excluding the inverted repeats
ﬂanking the aac(6′)-aph(2″) gene) and incorporate the MG_438 pro-
moter at the 5′ end. This PCR product was digested with BamHI di-
gested and ligated to a BamHI-digested pBSK.
pGmRCre (Supplementary Fig. S1D) was constructed as follows.
Cre recombinase gene was ampliﬁed by PCR from pSH6214 using
the primers 3_MluI_Cre and 5_pM438Cre, which incorporates the se-
quence of MG_438 promoter. The PCR product was then ligated to
vector pGmR previously digested with EcoRV.
2.4. Western immunobloting
Total mycoplasma protein extracts were subjected to electrophoresis
through a 12% SDS-polyacrylamide gel, transferred electrophoretically
to a PVDFmembrane (MerckMillipore) previously activated in metha-
nol and probed with a mouse polyclonal anti-MG217 antibodies38 at a
1:1,000 dilution. After primary antibody incubation, the membrane
was washed three times with PBS-0.05% Tween20 solution, incubated
for 1 h at room temperature with a HRP-conjugated anti-mouse IgG
(Sigma) at 1:5,000 dilution, washed three times with PBS-0.05%
Tween20 and revealed using Luminata Forte (Millipore) in a Imaging
System VersaDoc MP 4,000 (Bio-Rad). Then, the same membrane
was incubated with a rabbit polyclonal anti-P41 antibodies39 at
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1:1,000 dilution, washed three times with PBS-0.05% Tween20 solu-
tion and incubated for 1 h at room temperature with a phosphatase al-
kaline (PA) conjugated anti-rabbit IgG (Sigma) at 1:5,000 dilution.
After secondary antibody incubation, the membrane was washed
three times with PBS-0.05% Tween20 and revealed using NBT/BCIP
Solution (Roche) according to the manufacturer’s instructions.
2.5. Real-time PCR
Real-time PCR (qPCR) reactions were carried out using iTaq Univer-
sal SYBRGreen Supermix (Bio-rad) in a ﬁnal volume of 10 µl contain-
ing 4 µl of a 10−4 dilution of genomic DNAs, 0.5 µM of each primer
(Supplementary Table S2) and 5 µl of 2× SYBR Green Supermix. Re-
actions were run in a CFX384 PCR instrument (Bio-Rad) following a
three-step PCR protocol including an initial denaturation at 95°C for
3 min and 40 cycles comprising a denaturing step at 95°C for 20 s, an
annealing step at 56°C for 10 s and an extension step at 72°C for 10 s.
Fluorescence readings were acquired at the end of each extension step,
and the speciﬁcity of PCR products was veriﬁed by melting curve ana-
lyses at the end of each run.
Genome quantiﬁcation was performed using primers qPCR216F
and qPCR216R annealing to MG_216, a control gene located at the
5′ end of the target gene MG_217. Frequencies of genomes with ex-
cised cassettes were derived from qPCR reactions using primers
qPCR_217BD_UPS and qPCR_217BE_DWS. Frequencies of non-
excised genomes were derived from qPCR reactions using primers
qPCR_217BD_UPS and qPCR_CmDWS. T-student statistical ana-
lyses were carried out using the SPSS software. For each condition,
three biological repeats and two technical repeats were performed.
2.6. Cell viability, induction of Cre expression and
genomic DNA sequencing
To test Cre induction and expression, cell cultures were grown for 72 h
in the presence of 0, 0.1, 1, 10 and 100 ng ml−1 tetracycline. Then,
cells were recovered and small samples were plated in SP4-agar
and SP4-agar supplemented with 34 µg ml−1 chloramphenicol, incu-
bated for 3 weeks as described above until colonies could be scored.
T-student statistical analyses were carried out using the SPSS software.
Genomic DNAs were puriﬁed from the remaining cells and used as
template for qPCR assays. Five colonies from SP4 plates were also re-
covered and expanded to isolate genomic DNAs. Standard PCR reac-
tions using the primers 5 screening D217 and 3 screening D217 were
carried out to detect cassette excisions. All excisions were conﬁrmed
by Sanger sequencing performed at the Servei de Genòmica i Bioinfor-
màtica, IBB-Parc de Recerca UAB.
3. Results
3.1. Stability of suicide vectors in Mycoplasma
genitalium
Since no replicative vectors are available in M. genitalium, we tested
whether a suicide plasmid delivered by electroporation and bearing
a gentamicin resistance gene marker could remain inside the cells for
limited periods of time. To this end, the plasmid pGmR was engi-
neered (Supplementary Fig. S1C) and transformed on M. genitalium
G37 WT cells. These cells were then incubated in the presence of gen-
tamicin for 24, 48, 72, 96 and 168 h and were ﬁnally plated in
SP4-agar in the absence of antibiotic to quantify the number of viable
cfus remaining after the gentamicin treatment (Fig. 1A). About 104 co-
lonies were recovered from cells electroporated with pGmR, with no
appreciable differences between the different gentamicin incubation
times tested. In contrast, only a few colonies were recovered from
non-electroporated control cells, particularly after the longest genta-
micin incubation times. These results suggest that 104 cells incorporate
Figure 1. Persistence of a suicide vector inside M. genitalium cells and marker
gene excision by Cre recombinase. (A) G37 strain was electroporated with
pGmR or saline, and cells were incubated with gentamicin 100 µg ml−1 for 24,
48, 72, 96 and 168 h. Cells were then plated in SP4-agar medium and colonies
were scored. Three independent repeats for each condition were performed,
and the mean with its standard error (SE) is plotted. (B) G37 and TcloxCm
strains were transformed with of pGmRCre and saline, and cells were
incubated in SP4 medium containing gentamicin 100 µg ml−1 for 48, 72 and
168 h. Cells were then plated in SP4-agar medium and colonies were scored.
Three independent repeats and two technical replicates were performed for
each strain and condition, and the mean values with its standard error (SE) are
plotted. (C) Colonies from TcloxCm strain electroporated with or without
pGmRCre and incubated in SP4 medium containing gentamicin 100 µg ml−1
for 48, 72 and 168 h were recovered and expanded to isolate genomic DNAs.
Genomic DNAs were ampliﬁed by PCR with the primers Seq tet DWS300 and
Seq 5 IR-OR-Lox66 3′. A 1,118-bp PCR band is expected from genomic DNAs
bearing the cat gene and a 246-bp PCR band is expected in those genomes
with a excision of this selectable marker.
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the pGmR plasmid when delivered by electroporation, gentamicin
marker remains functional inside these cells at least for several days,
and gentamicin is killing most of the plasmid-free cells.
3.2. Evaluation of the Cre-Lox system
To evaluate the feasibility of Cre-lox system inM. genitalium, we ﬁrst
obtained a mutant strain including an antibiotic marker gene ﬂanked
by two lox66 sequences. To this purpose, we engineered the minitran-
sposon pMTnTc66Cat66 which carries the tetracycline resistance
gene and also the chloramphenicol acetyltransferase gene (cat) that
was ﬂanked by two lox66 sequences (Supplementary Fig. S1B). This
minitransposon was transformed on M. genitalium cells and several
recovered colonies were grown in liquid culture, and their DNAs
were extracted and analysed by direct genome sequencing to conﬁrm
the presence of the minitransposon and to determine the genomic in-
sertion points. One of the clones recovered was named TcloxCm and
selected for further studies. On the other hand, we also constructed the
suicide plasmid pGmRCre bearing the Cre recombinase gene under
the control of MG_438 constitutive promoter (Supplementary Fig.
S1D). This construct was expected to promote the expression of Cre
recombinase once introduced to M. genitalium cells.
Plasmid pMTnTc66Cat66 was designed to easily detect the cat
cassette excision in TcloxCm mutants both by plating cells in a selec-
tive medium and by PCR ampliﬁcation. Encouraged by the apparent
stability of suicide vectors insideM. genitalium cells, we transformed a
TcloxCmmutant with and without the pGmRCre plasmid and result-
ing cells were further incubated for 48, 72 and 168 h in the presence of
gentamicin. TcloxCm viable cells remaining after the different genta-
micin incubation times were also quantiﬁed, with results similar to
those obtained when using pGmR plasmid (Fig. 1B). To assess the ex-
cision of cat cassette, ﬁve clones recovered from each experimental
condition were checked by PCR. After 48 h of gentamicin incubation,
all recovered clones showed a 1,118-bp PCR band consistent with the
presence of the cat gene ﬂanked by two lox66 sequences. Fortunately,
after 72 and 168 h of gentamicin incubation, all recovered clones ex-
hibited a single 246-bp PCR band consistent with the excision of cat
cassette (Fig. 1C). These clones were able to grow in SP4 medium, but
no growth was observed when they were cultured in SP4 medium sup-
plemented with chloramphenicol, conﬁrming also the absence of cat
gene. None of the few clones recovered from control TcloxCm cells
electroporated in the absence of pGmRCre plasmid and incubated
with gentamicin showed the excision of the marker cassette
(Fig. 1C). All these results indicate that Cre recombinase expression
directed by pGmRCre plasmid has no noticeable toxic effects in M.
genitalium cells, and this enzyme efﬁciently excises sequences ﬂanked
by lox in this microorganism.
3.3. Cre expression under the control of an inducible
promoter
Genome engineering in a minimal cell model likeM. genitalium would
be greatly beneﬁted from the existence of working constructs bearing an
inducible Cre recombinase gene by providing a simple way to geneti-
cally modify cells in a single transformation step. As proof of concept,
we chose to obtain an unmarked deletion ofMG_217 gene, which has
been previously shown to be easily deleted by homologous gene repla-
cement.40 First, we designed the plasmid pΔMG_217Cre containing a
cassette including the tetR repressor gene under the control of spiralin
promoter,31 the Cre recombinase gene under the control of a tailored
version of the inducible Pxyl/TetO2 promoter from pMT85-XTST
31
(named Pxyl/TetO2mod) and cat gene as the selectable marker.
Pxyl/tetO2 was engineered to minimize the transcriptional leakage ex-
hibited by this promoter simply by removing the sequence including
the ribosome binding site at the 3′ end of this DNA fragment (Supple-
mentary Fig. S3). With this modiﬁcation, we expected a strong decrease
in translation efﬁciencyof Cre recombinase, greatly reducing the expres-
sion of this enzyme in the absence of inducer (Supplementary Fig. S4).
The whole cassette, which was named Cre-cat cassette, was ﬂanked by
two lox66 sequences and enclosed by the same ﬂanking regions pre-
viously used to obtain the MG_217 null mutant40 (Supplementary
Fig. S1A). A double cross-over recombination event between plasmid
pΔMG_217Cre and M. genitalium genome is expected to promote
the deletion from bases 60 to 980 of the MG_217 gene (82.2% of
the coding region) and the replacement of this region by the cassette
ﬂanked by lox66 sequences (Fig. 2A).
To obtain the ΔMG_217Cre strain, WT cells were electroporated
with pΔMG_217Cre plasmid and transformant colonies were isolated
on SP4medium containing chloramphenicol. Several colonies were ex-
panded, and their genomic DNAs were analysed by PCR to check the
presence of the intended replacement (Fig. 2A). All clones recovered
showed a 5075-bp band consistent with the deletion of MG_217
gene and its replacement by Cre-cat cassette (Fig. 2B). To further con-
ﬁrm the deletion ofMG_217 gene, awestern blot was performed using
the mouse polyclonal anti-MG217 antibodies.40 A 60 kDa band cor-
responding to MG217 protein was detected in G37 wild-type strain,
but it was not present in any of the recovered clones (Fig. 2C).
Preliminary time-course experiments revealed that most of the
Cre-cat cassettes in M. genitalium genomes were found excised after
72 h of culture with 10 ng/ml tetracycline (data not shown). Next, sev-
eral independent clones of ΔMG_217Cre strain were grown for 72 h at
different tetracycline concentrations to optimize Cre expression. These
induced cultures were then plated in SP4-agar to quantify all viable
cells and also in chloramphenicol-SP4-agar plates to quantify the
viable cells still bearing the cat gene (Fig. 3A). In the presence of the
lowest inductor concentration tested 70% of cells could grow in
the presence of chloramphenicol, and only around a 10% of cells in-
cubated with the highest tetracycline concentrations were still found
resistant to chloramphenicol. The excision of the Cre-cat cassette
was also quantiﬁed by qPCR (Fig. 3B), obtaining similar results and
indicating that >90% of the cell population excised this cassette
when incubated with tetracycline at concentrations higher than 1 ng
ml−1. No statistically signiﬁcant differences were found in the fre-
quency of genomes with excised cassettes upon inducing Cre expres-
sion at 1, 10 or 100 ng ml−1 tetracycline (Fig. 3A and B). The presence
of genomes with excised cassettes was ﬁnally checked by PCR in ﬁve
isolated clones recovered after incubating with 10 ng ml−1 tetracycline
for 72 h. These clones showed a 2195-bp PCR band consistent with
the excision of Cre-cat cassette (Fig. 3C). We also determined the se-
quence of the excised cassettes by direct Sanger sequencing of genomic
DNAs from these clones. Sequence analyses demonstrated that all the
clones analysed have the same DNA sequence inside the excised cas-
settes (data not shown). All these data taken together indicate that Cre
expression is efﬁciently induced in the presence of tetracycline, and the
amounts of recombinase produced are enough to precisely excise
DNA regions ﬂanked by lox66 sequences.
3.4. Stability of lox66 cassettes in long-term uninduced
cultures
Some applications using the Cre-lox technology may require a strict
control on Cre recombinase expression. To obtain quantitative
data about the transcriptional leakage of Pxyl/TetO2mod promoter
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in ΔMG_217Cre strain, the stability of Cre-cat cassette in this strain
was tested after 1, 6 and 11 serial culture passages in the absence of
inducer and chloramphenicol. Cells from these culture passages were
plated in SP4-agar and chloramphenicol-SP4-agar, and no statistically
signiﬁcant differences in the number of viable cells plated in both con-
ditions were observed at the different culture passages (Fig. 4A). A
more precise quantiﬁcation of the genomes with excised Cre-cat cas-
settes was made by qPCR. Only a 0.53% of the cell genomes isolated
after the ﬁrst culture passage exhibited excised cassettes. The number
of excised cassettes slightly increased in the cell genomes isolated after
6 and 11 serial passages, showing frequencies of 1.36 and 4.50%,
respectively (Fig. 4B) and indicating that Cre expression in ΔMG_
217Cre cells is strongly repressed in the absence of inducer.
4. Discussion
Mycoplasmas are widely used for synthetic biology studies including
modiﬁed genome transplantations.21,22,41–43 Although their genomes
can be synthesized chemically with the desired mutations and then as-
sembled in yeast cells,20,43 this is a difﬁcult and time-consuming pro-
cess that may not apply for high-throughput studies. Furthermore,
transposition or gene replacement is nowadays a quicker, easier and
cheaper way to obtain genetic modiﬁcations. Since Cre-lox technology
is not currently available in mycoplasmas, we chose to adapt this
friendly user technology as a new genetic tool for working with
these microorganisms. Among multiple beneﬁts, the Cre-lox system
makes possible the removal of marker genes, allowing multiple rounds
of genome editions. In this way, combining Cre technology and either
homologous gene replacement or transposition may allow in minimal
genome studies to introduce sequential gene deletions after removing
the marker genes.
As the ﬁrst step to implement the Cre-lox technology inM. genita-
lium, we tested the Cre expression when delivered by suicide plasmid44
and demonstrated that cells transformed by a suicide plasmid remain
viable in the presence of a selective medium for several days (Fig. 1A
and B). Our data also indicate that >99% of viable cells recovered in
the presence of a selective medium were transformed with the suicide
plasmid, suggesting that the background of these experiments was
very low, being the frequency of spontaneous gentamicin-resistant
cells lower than 1% of viable cells. This suicide plasmid was also
proved a very effective way to promote the Cre recombinase expres-
sion inside mycoplasma cells since all examined clones showed the ex-
cision of a lox66 cassette 48 h after plasmid delivering (Fig. 1C). Since
no excision of this cassette was detected in the absence of the suicide
vector, we can discard the presence of intrinsic Cre-like recombinases
in M. genitalium.
Once it was demonstrated the Cre recombinase function inM. gen-
italium, we developed an all-in-one vector to introduce in a single
Figure 2. Obtaining a ΔMG_217Cre deletion mutant. (A) Schematic representation of recombination events between the pΔMG_217Cre suicide vector and theMG_217
gene in G37 strain. PCR bands expected when using 5 screening D217 and 3 screening D217 primers to amplify G37, ΔMG_217_Cre and ΔMG_217_Cre genomic DNAs
are also indicated. Primers are shown as coloured arrows in each strain and numbered as follows: (1) 5 screening D217; (2) 3 screening D217; (3) qPCR 217BE_DWS; (4)
qPCR CmDWS; (5) qPCR 217BD_UPS; (6) 5 XhoI SacI BEmg217; (7) 3 SpeI AscI BEmg217; (8) 5 ApaI BDmg217 and (9) 3 BamHI NotI BDmg217. (B) Genomic DNAs from
G37 and ΔMG_217_Cre strainswere ampliﬁed by PCR using 5 screening D217 and 3 screening D217 primers (1 and 2). (C)Western Blot analyses of protein extracts from
G37 and ΔMG_217_Cre strains.MG_217 protein was detected using amouse anti-MG_217 polyclonal antibodies and a rabbit polyclonal antiserumanti-P41 was used as
a loading control. This ﬁgure is available in black and white in print and in colour at DNA Research online.
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transformation step both a genome modiﬁcation and an inducible ver-
sion Cre recombinase gene. This saving-time technology would be
especially interesting for those microorganisms with slow growing
rates like mycoplasmas. To this end, a Cre-cat cassette was designed
to include a Pxyl/TetO2 tetracycline-inducible system31 which was
modiﬁed to improve the control on Cre expression. The presence of
Cre-cat cassette did not interfere in the gene replacement experiments,
and the ΔMG_217Cre mutant was obtained with a transformation ef-
ﬁciency of 2 × 10−7 per viable cell, virtually the same transformation
efﬁciency that was described in a previous report.40 In addition, this
mutant exhibited the same phenotype as previously described (data
not shown) suggesting that the presence of Cre-cat cassette is not
toxic for mycoplasma cells and no polar effects are produced on
MG_217 ﬂanking genes. We also tested the effect of different tetracy-
cline concentrations when inducing Cre expression by quantifying the
frequency of the cassette excisions in genomes of ΔMG_217Cre cells.
Cre expression was detected at tetracycline concentrations as low as
0.1 ng ml−1, and the maximum expression ratewas reached at concen-
trations close to 1 ng ml−1, which is 200 times below the minimal in-
hibitory concentration of this antibiotic in M. genitalium.34 When
using Cre-cat cassette in microorganisms very sensitive to tetracycline,
this antibiotic might be replaced by anhydrotetracycline, a less toxic
tetracycline analogue45 that can also be used to induce Tet promoters.
Implementing the Cre-lox system in mycoplasmas opens a new
horizon in the study of these minimal microorganisms. With this tech-
nology a huge variety of genome modiﬁcations, such as insertions, de-
letions, translocations and inversions at speciﬁc sites, can be achieved
now in mycoplasmas. Once demonstrated that lox66 sequences and
Figure 3.Cre recombinase expression tests. (A) Cell cultures containing several
isolates of ΔMG_217Cre strain were grown with 0, 0,1, 1, 10 or 100 ng/ml
tetracycline for 72 h and plated in SP4-agar plates and in SP4-agar plates
supplemented with 34 µg/ml chloramphenicol. For each condition, three
independent biological replicates and four technical repeats were performed.
The frequency of chloramphenicol-resistant cfus was plotted for each
condition with standard error bars. Asterisk symbol indicated statistical
signiﬁcant differences with a P-value <0.05. (B) Genomic DNAs from cell
cultures in A were analysed by qPCR to quantify the Cre-cat cassette excision
using primers qPCR CmDWS–qPCR 217BD_UPS and qPCR 217BE_DWS–qPCR
217BD_UPS. The frequency of the three biological repeats is plotted with its
respective standard error bars. Asterisk symbol indicated statistical
signiﬁcant differences with a P-value <0.05. (C) A ΔMG_217_Cre mutant was
grown in SP4 medium containing 10 ng m−1 tetracycline for 72 h, and cells
were plated in SP4-agar medium. Five colonies were recovered and
expanded to isolate genomic DNAs. Cre-cat cassette excision was inspected
by PCR using primers 5 screening D217 and 3 screening D217. Outline and
expected bands are shown in Fig. 2A.
Figure 4. Stability of lox66 cassettes in long-term uninduced cultures. (A)
ΔMG_217Cre strain was subjected up to 11 serial culture passages in the
absence of tetracycline inducer and chloramphenicol. Each passage was
started using 1% of cells of the previous passage. At passages 1, 6 and 11,
cell samples were plated in SP4-agar medium and SP4-agar medium
supplemented with chloramphenicol 34 µg ml−1. For each passage, three
independent biological replicates and four technical repeats were analysed.
The frequency of chloramphenicol resistant cfus in the analysed passages is
plotted with standard error bars. (B) Genomic DNAs from cell cultures in A
were analysed by qPCR to quantify the Cre-catcassette excision using
primers qPCR CmDWS–qPCR 217BD_UPS and qPCR 217BE_DWS–qPCR
217BD_UPS.
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Cre recombinase are functional in M. genitalium, it seems feasible to
use a combination of lox66 and lox71 sequences. Recombination be-
tween these two lox sites generates an inert lox72 sequence, which pre-
sents extremely reduced recombination efﬁciency.12 Although a huge
repertory of non-compatible lox sequences is currently avail-
able,12,13,15,46 the lox72 seems the most suitable sequence to obtain
an unlimited number of genetic modiﬁcations without interferences
between different lox sequences.12
The RBS sequence at the 3′ end of Pxyl/TetO2 was removed to ob-
tain a promoter with an improved control on the expression of target
genes. The leakage of the modiﬁed version of this promoter was tested
using a very sensitive assay. This assay was designed to detect and quan-
tify by qPCR the frequency of excised Cre-cat cassettes in serial passage
cultures of ΔMG_217Cre cells in the absence of inducer. After 11 serial
passages, i.e. more than a month of continuous cell culture, only 4.5%
of the total cell population underwent a cassette excision. As only four
molecules of Cre recombinase are needed to perform a site-speciﬁc re-
combination,47 our results suggest that Cre expression is tightly con-
trolled. In addition, if the Cre-cat cassette is wanted to be strictly
maintained, the addition chloramphenicol to the culture medium
would kill those cells bearing excised the cassettes, resulting in a negli-
gible cell mortality rate at every passage. Finally, the modiﬁcations in-
troduced in Pxyl/TetO2 also make this inducible promoter a promising
tool for other molecular applications. A tight control of the expressed
genes is essential to develop conditional knock-out mutants to study
the function of essential genes, the introduction of inducible counterse-
lectable markers and the evaluation of mutant phenotypes after indu-
cing the expression of target genes in time-course experiments.
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